oxybutynin has been researched along with Experimental Neoplasms in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ye, Y | 1 |
| Wang, C | 1 |
| Zhang, X | 1 |
| Hu, Q | 1 |
| Zhang, Y | 1 |
| Liu, Q | 1 |
| Wen, D | 1 |
| Milligan, J | 1 |
| Bellotti, A | 1 |
| Huang, L | 1 |
| Dotti, G | 1 |
| Gu, Z | 1 |
1 other study available for oxybutynin and Experimental Neoplasms
| Article | Year |
|---|---|
A melanin-mediated cancer immunotherapy patch.
Topics: Animals; Cancer Vaccines; Cell Line, Tumor; Dendritic Cells; Female; Immunotherapy; Infrared Rays; K | 2017 |